High-Density Lipoprotein and High-Density Lipoprotein Cholesterol

Kayla A. Riggs, Anand Rohatgi

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


The relationship between HDL metabolism and atherosclerotic cardiovascular disease (ASCVD) is complex. This chapter focuses on three key aspects reflecting HDL metabolism: HDL cholesterol concentration (HDL-C), HDL particle number (HDL-P), and HDL function. The epidemiology of circulating markers, genetics, and effects of interventions on HDL metabolism will be reviewed, emphasizing data from large population-based cohorts and randomized clinical trials. A specific emphasis is placed on recent findings related to HDL functions such as cholesterol efflux, endothelial nitric oxide, oxidation, and platelet suppression, as well as on recent trials of cholesteryl ester transfer protein inhibitors, including torcetrapib, dalcetrapib, evacetrapib, and anacetrapib.

Original languageEnglish (US)
Title of host publicationBiomarkers in Cardiovascular Disease
Number of pages9
ISBN (Electronic)9780323548359
StatePublished - Jan 1 2018


  • CETP inhibitor
  • Cholesterol efflux capacity
  • Cholesteryl ester transfer protein inhibitor
  • HDL
  • HDL-C
  • HDL-P
  • High-density lipoprotein
  • High-density lipoprotein concentration
  • High-density lipoprotein particle number
  • Niacin

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'High-Density Lipoprotein and High-Density Lipoprotein Cholesterol'. Together they form a unique fingerprint.

Cite this